Pathogenic Salmonella serovars are a major cause of enteric illness in humans and animals, and produce clinical manifestations ranging from localized gastroenteritis to systemic disease. T cells are a critical component of immunity against this intracellular pathogen. The mechanisms by which Salmonella modulates T-cell – mediated immune responses in order to establish systemic infection are not completely understood. We show that infection of mice with Salmonella enterica serovar Typhimurium (S.Typhimurium) suppresses IL-2 and increases IFN- and IL-17 production from T cells activated in vivo or ex vivo through the T cell receptor. Infection with S.Typhimurium brings about recruitment of CD11b+Gr1+ myeloid derived suppressor cells (MDSCs) to the spleen. Ex vivo depletion of these cells restores the ability of activated T cells to produce IL-2 and brings secretion of IFN- and IL-17 from these cells back to basal levels. The reduction in IL-2 secretion is not seen in IFN--/- and iNOS-/- mice infected with Salmonella. Our findings demonstrate that sustained innate activated IFN- production during progression of infection with Salmonella reduces IL-2 – secreting capability of T cells through an iNOS-mediated signaling pathway that can adversely affect long term immunity against this pathogen.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: